Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Some High-Cholesterol Genes Differ Between Countries

By LabMedica International staff writers
Posted on 09 Oct 2019
Genome-wide association studies (GWAS) have been very successful in identifying genetic variants linked to cardiovascular disease (CVD) and to cardiometabolic traits. More...
Due to the improving predictive accuracy of these variants, genetic risk prediction could soon be implemented in clinical settings.

Previous studies have assessed the effects of different allele frequencies and linkage disequilibrium (LD) on genetic associations across ancestry groups. Heterogeneity in effects of variants could result from epistasis or gene-environment interactions. However, the causal variants are usually unknown. Differences in allele frequency also impact the power to detect associations in other ancestry groups.

A large group of scientists led by those at University College London (London, UK) investigated the known genetic variants that affect blood lipid levels, a major cardiovascular risk factor, to test whether they applied to different groups in the UK, Greece, China, Japan and Uganda. For the Chinese participants 102,783 participants were genotyped using two custom-designed Affymetrix Axiom arrays that included up to 803 K variants, optimized for genome-wide coverage in these populations.

A list of established lipid-associated loci was extracted from the latest Global Lipid Genetics Consortium (GLGC2017) publication reporting 444 independent variants in 250 loci associated at genome-wide significance with high-density lipoprotein (HDL), and low-density lipoprotein (LDL), and triglyceride levels. The team assessed evidence that these established lipid signals are reproducible in other populations. For loci harboring multiple signals, they only kept the most strongly associated variant.

The team found that the results were broadly consistent across European and Asian groups, with about three quarters of genetic markers applied similarly across the different groups, but only 10% of the genetic markers for triglycerides (the most common type of fat in the body) were implicated in the same cardiovascular risk factors among people from Uganda. The scientists pointed out that even if genetics are nearly universal, environments are more variable, and some genes may have different, undiscovered effects in different environments. Genes predicting high cholesterol may not be risky for people with diets and lifestyles typical of rural Uganda.

Karoline Kuchenbaecker, PhD, an associate professor and lead author of the study, said, “Genome-wide association studies, facilitated by the mapping of the human genome, have transformed our understanding of how our genetics impact our traits, behaviors and disease risks. But the large majority of them have been conducted in people of European descent, so there's a growing concern that the findings might not uniformly apply to people of diverse backgrounds.” The study was published on September 24, 2019, in the journal Nature Communications.

Related Links:
University College London


Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Portable Electronic Pipette
Mini 96
ESR Analyzer
TEST1 2.0
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The enhanced collaboration builds upon the successful launch of the AmplideX Nanopore Carrier Plus Kit in March 2025 (Photo courtesy of Bio-Techne)

Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded its agreement with Oxford Nanopore Technologies (Oxford, UK) to broaden Bio-Techne's ability to develop a portfolio of genetic products on Oxford... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.